Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer.

Cottu, P H; Asselah, J; Lae, M; Pierga, J-Y; Diéras, V; Mignot, L; Sigal-Zafrani, B; Vincent-Salomon, A

Cottu, P H; Asselah, J; Lae, M; Pierga, J-Y; Diéras, V; Mignot, L; Sigal-Zafrani, B; Vincent-Salomon, A.

Afiliação

Cottu PH; Department of Medical Oncology. Electronic address: paul.cottu@curie.net.
Asselah J; Department of Medical Oncology.
Lae M; Department of Pathology, Institut Curie, 26 rue d'Ulm, 75005 Paris, France.
Pierga JY; Department of Medical Oncology.
Diéras V; Department of Medical Oncology.
Mignot L; Department of Medical Oncology.
Sigal-Zafrani B; Department of Pathology, Institut Curie, 26 rue d'Ulm, 75005 Paris, France.
Vincent-Salomon A; Department of Pathology, Institut Curie, 26 rue d'Ulm, 75005 Paris, France.

Ann Oncol ; 19(3): 596-597, 2008 Mar.

Article em En | MEDLINE | ID: mdl-32560012

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Oncol Ano de publicação: 2008 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Oncol Ano de publicação: 2008 Tipo de documento: Article